PIWIL4 and SUPT5H were identified and validated as novel prognostic biomarkers via bioinformatics and laboratory experiments, and a signature was developed to predict the prognosis and risk classifiers of ICC patients. The gene discussed is SUPT5H; the disease is intrahepatic cholangiocarcinoma.